BridgeBio’s Attruby outperforms sales expectations, shares rise

Elizabeth Cairns

Senior biopharma journalist

When BridgeBio reported Attruby prescription numbers in February, the figures came in substantially above analyst projections. Now the company has pulled off …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BridgeBio’s Attruby outperforms sales expectations, shares rise

Elizabeth Cairns

Senior biopharma journalist

Sign up to read this article for free.

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

RFK Jr. spars with senators over research cuts, HHS budget plan

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Bridge­Bio’s At­tru­by out­per­forms sales ex­pec­ta­tions, shares rise

Elizabeth Cairns

Senior biopharma journalist

Sign up to read this article for free.

Up­dat­ed: Trump ad­min­is­tra­tion re­veals 'most fa­vored na­tion' drug price coun­try tar­gets

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

Up­dat­ed: FDA ad­comm splits votes on Genen­tech and J&J can­cer drugs

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

RFK Jr. spars with sen­a­tors over re­search cuts, HHS bud­get plan

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

BridgeBio’s Attruby outperforms sales expectations, shares rise

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

RFK Jr. spars with senators over research cuts, HHS budget plan

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?